Insight Molecular Diagnostics (IMDX) Other Gross PP&E Adjustments: 2020-2025
Historic Other Gross PP&E Adjustments for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to -$12.9 million.
- Insight Molecular Diagnostics' Other Gross PP&E Adjustments fell 15.02% to -$12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.7 million, marking a year-over-year decrease of 21.91%. This contributed to the annual value of -$11.5 million for FY2024, which is 23.63% down from last year.
- As of Q3 2025, Insight Molecular Diagnostics' Other Gross PP&E Adjustments stood at -$12.9 million, which was down 2.10% from -$12.6 million recorded in Q2 2025.
- Over the past 5 years, Insight Molecular Diagnostics' Other Gross PP&E Adjustments peaked at $4.7 million during Q2 2021, and registered a low of -$15.7 million during Q3 2022.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$11.5 million (2024), whereas its average is -$11.5 million.
- In the last 5 years, Insight Molecular Diagnostics' Other Gross PP&E Adjustments spiked by 441.68% in 2021 and then plummeted by 462.48% in 2023.
- Over the past 5 years, Insight Molecular Diagnostics' Other Gross PP&E Adjustments (Quarterly) stood at -$4.5 million in 2021, then tumbled by 203.02% to -$13.7 million in 2022, then spiked by 32.45% to -$9.3 million in 2023, then declined by 23.63% to -$11.5 million in 2024, then fell by 15.02% to -$12.9 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$12.9 million for Q3 2025, versus -$12.6 million for Q2 2025 and -$12.7 million for Q1 2025.